Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children

被引:4
作者
Wingler, Mary Joyce B. [1 ]
Tamma, Pranita D. [2 ]
机构
[1] Univ Mississippi, Dept Antimicrobial Stewardship, Med Ctr, 2500 N State St, Jackson, MS 39216 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
关键词
antibiotic stewardship; community-acquired pneumonia; pediatric; urinary tract infection; ACUTE UNCOMPLICATED CYSTITIS; LEVOFLOXACIN; 750; MG; SHORT-COURSE CIPROFLOXACIN; SINGLE-DOSE FOSFOMYCIN; DOUBLE-BLIND; OPEN-LABEL; TRIMETHOPRIM-SULFAMETHOXAZOLE; AMOXICILLIN-CLAVULANATE; ACUTE PYELONEPHRITIS; LORACARBEF LY163892;
D O I
10.1097/QCO.0000000000000857
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Purpose of review Community-acquired pneumonia (CAP) and urinary tract infections (UTI) are two common childhood infections often leading to hospital admission. National guidelines for CAP and UTI in children recommend durations of antibiotic therapy of 10 days and 7-14 days, respectively. Due to concerns of rising antimicrobial resistance and an increased awareness of harms associated with prolonged courses of antibiotics, there is a renewed emphasis on reevaluating commonly prescribed durations of antibiotic therapy across bacterial infections. We describe recent clinical trials and observational studies evaluating durations of therapy for CAP and UTI in adults and children and translate the findings to our suggested approach for selecting durations of antibiotic therapy in hospitalized children. Recent findings There is a growing body of evidence, primarily in adults, that shorter durations of therapy than are commonly prescribed are just as effective as longer durations for CAP and UTIs. Combining clinical trial data from adults with available data in children, we believe it is reasonable to consider 5 days of therapy for CAP, 3-5 days of therapy for cystitis, and 7 days of therapy for pyelonephritis for most hospitalized children with uncomplicated infections.
引用
收藏
页码:442 / 451
页数:10
相关论文
共 86 条
  • [1] Association of Antibiotic Treatment Duration With Recurrence of Uncomplicated Urinary Tract Infection in Pediatric Patients
    Afolabi, Titilola M.
    Goodlet, Kellie J.
    Fairman, Kathleen A.
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 757 - 766
  • [2] A brief history of the antibiotic era: lessons learned and challenges for the future
    Aminov, Rustam I.
    [J]. FRONTIERS IN MICROBIOLOGY, 2010, 1
  • [3] [Anonymous], 1981, B WORLD HEALTH ORGAN, V59, P707
  • [4] [Anonymous], 2012, SCOUT STUDY SHORT CO
  • [5] [Anonymous], 2016, FDA DRUG SAFETY COMM
  • [6] Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections:: a randomized, multicentre, open-label, prospective study
    Arredondo-García, JL
    Figueroa-Damián, R
    Rosas, A
    Jáuregui, A
    Corral, M
    Costa, A
    Merlos, RM
    Ríos-Fabra, A
    Amábile-Cuevas, CF
    Hernández-Oliva, GM
    Olguín, J
    Cardeñosa-Guerra, O
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) : 840 - 843
  • [7] Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
  • [8] Bergman DA, 1999, PEDIATRICS, V103, P843
  • [9] Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia The CAP-IT Randomized Clinical Trial
    Bielicki, Julia A.
    Stohr, Wolfgang
    Barratt, Sam
    Dunn, David
    Naufal, Nishdha
    Roland, Damian
    Sturgeon, Kate
    Finn, Adam
    Rodriguez-Ruiz, Juan Pablo
    Malhotra-Kumar, Surbhi
    Powell, Colin
    Faust, Saul N.
    Alcock, Anastasia E.
    Hall, Dani
    Robinson, Gisela
    Hawcutt, Daniel B.
    Lyttle, Mark D.
    Gibb, Diana M.
    Sharland, Mike
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (17): : 1713 - 1724
  • [10] COMPARISON OF CEFADROXIL AND CEPHALEXIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
    BLASER, MJ
    KLAUS, BD
    JACOBSON, JA
    KASWORM, E
    LAFORCE, FM
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (02) : 163 - 167